168 related articles for article (PubMed ID: 22381385)
1. Evaluation of health-care utilization among adult patients with epilepsy in Germany.
Strzelczyk A; Nickolay T; Bauer S; Haag A; Knake S; Oertel WH; Reif PS; Rosenow F; Reese JP; Dodel R; Hamer HM
Epilepsy Behav; 2012 Apr; 23(4):451-7. PubMed ID: 22381385
[TBL] [Abstract][Full Text] [Related]
2. Direct and indirect costs of refractory epilepsy in a tertiary epilepsy center in Germany.
Hamer HM; Spottke A; Aletsee C; Knake S; Reis J; Strzelczyk A; Oertel WH; Rosenow F; Dodel R
Epilepsia; 2006 Dec; 47(12):2165-72. PubMed ID: 17201718
[TBL] [Abstract][Full Text] [Related]
3. Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany.
Strzelczyk A; Haag A; Reese JP; Nickolay T; Oertel WH; Dodel R; Knake S; Rosenow F; Hamer HM
Epilepsy Behav; 2013 Jun; 27(3):433-8. PubMed ID: 23591262
[TBL] [Abstract][Full Text] [Related]
4. Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany from 2003 to 2013 - A ten-year overview.
Willems LM; Richter S; Watermann N; Bauer S; Klein KM; Reese JP; Schöffski O; Hamer HM; Knake S; Rosenow F; Strzelczyk A
Epilepsy Behav; 2018 Jun; 83():28-35. PubMed ID: 29649671
[TBL] [Abstract][Full Text] [Related]
5. Costs of epilepsy and cost-driving factors in children, adolescents, and their caregivers in Germany.
Riechmann J; Strzelczyk A; Reese JP; Boor R; Stephani U; Langner C; Neubauer BA; Oberman B; Philippi H; Rochel M; Seeger J; Seipelt P; Oertel WH; Dodel R; Rosenow F; Hamer HM;
Epilepsia; 2015 Sep; 56(9):1388-97. PubMed ID: 26235849
[TBL] [Abstract][Full Text] [Related]
6. [Survey of adults living with epilepsy in Hungary: health-related quality of life and costs].
Péntek M; Bereczki D; Gulácsi L; Mikudina B; Arányi Z; Juhos V; Baji P; Brodszky V
Ideggyogy Sz; 2013 Jul; 66(7-8):251-61. PubMed ID: 23971356
[TBL] [Abstract][Full Text] [Related]
7. A prospective study on the cost-effective utilization of long-term inpatient video-EEG monitoring in a developing country.
Chemmanam T; Radhakrishnan A; Sarma SP; Radhakrishnan K
J Clin Neurophysiol; 2009 Apr; 26(2):123-8. PubMed ID: 19279502
[TBL] [Abstract][Full Text] [Related]
8. Inpatient treatment costs of status epilepticus in adults in Germany.
Strzelczyk A; Knake S; Oertel WH; Rosenow F; Hamer HM
Seizure; 2013 Dec; 22(10):882-5. PubMed ID: 23992788
[TBL] [Abstract][Full Text] [Related]
9. [Direct medical costs of (severe) obesity: a bottom-up assessment of over- vs. normal-weight adults in the KORA-study region (Augsburg, Germany)].
von Lengerke T; Reitmeir P; John J
Gesundheitswesen; 2006 Feb; 68(2):110-5. PubMed ID: 16482491
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of health-care utilization in patients with Dravet syndrome and on adjunctive treatment with stiripentol and clobazam.
Strzelczyk A; Schubert-Bast S; Reese JP; Rosenow F; Stephani U; Boor R
Epilepsy Behav; 2014 May; 34():86-91. PubMed ID: 24727467
[TBL] [Abstract][Full Text] [Related]
11. Direct medical costs of COPD--an excess cost approach based on two population-based studies.
Menn P; Heinrich J; Huber RM; Jörres RA; John J; Karrasch S; Peters A; Schulz H; Holle R;
Respir Med; 2012 Apr; 106(4):540-8. PubMed ID: 22100535
[TBL] [Abstract][Full Text] [Related]
12. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
Phanthunane P; Whiteford H; Vos T; Bertram M
J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
[TBL] [Abstract][Full Text] [Related]
13. Economic burden of epilepsy in a developing country: a retrospective cost analysis in China.
Hong Z; Qu B; Wu XT; Yang TH; Zhang Q; Zhou D
Epilepsia; 2009 Oct; 50(10):2192-8. PubMed ID: 19583782
[TBL] [Abstract][Full Text] [Related]
14. Healthcare utilization and costs in adults with stable and uncontrolled epilepsy.
Cramer JA; Wang ZJ; Chang E; Powers A; Copher R; Cherepanov D; Broder MS
Epilepsy Behav; 2014 Feb; 31():356-62. PubMed ID: 24239435
[TBL] [Abstract][Full Text] [Related]
15. Neurologist adherence to clinical practice guidelines and costs in patients with newly diagnosed and chronic epilepsy in Germany.
Strzelczyk A; Bergmann A; Biermann V; Braune S; Dieterle L; Forth B; Kortland LM; Lang M; Peckmann T; Schöffski O; Sigel KO; Rosenow F
Epilepsy Behav; 2016 Nov; 64(Pt A):75-82. PubMed ID: 27732920
[TBL] [Abstract][Full Text] [Related]
16. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study.
Faught RE; Weiner JR; Guérin A; Cunnington MC; Duh MS
Epilepsia; 2009 Mar; 50(3):501-9. PubMed ID: 19183224
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC
J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311
[TBL] [Abstract][Full Text] [Related]
18. Prospective association of low serum total testosterone levels with health care utilization and costs in a population-based cohort of men.
Haring R; Baumeister SE; Völzke H; Kohlmann T; Marschall P; Flessa S; Nauck M; Wallaschofski H
Int J Androl; 2010 Dec; 33(6):800-9. PubMed ID: 20059581
[TBL] [Abstract][Full Text] [Related]
19. Healthcare utilization and costs of patients with rosacea in an insured population.
Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
[TBL] [Abstract][Full Text] [Related]
20. Analysis of direct, indirect, and intangible costs of epilepsy.
Pato Pato A; Cebrián Pérez E; Cimas Hernando I; Lorenzo González JR; Rodríguez Constenla I; Gude Sampedro F
Neurologia; 2011; 26(1):32-8. PubMed ID: 21163205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
